)
Esperion Therapeutics (ESPR) investor relations material
Esperion Therapeutics EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Chairperson called the meeting to order at 8:00 A.M. and outlined the rules of conduct and agenda.
Notice of the meeting and proxy statement were distributed to stockholders of record as of May 28, 2026.
Quorum was confirmed, with a majority of voting power present virtually or by proxy.
Specific resolutions to be voted on
Approval of the Agreement and Plan of Merger with Essence Parent and Essence MergerCo, making the company a wholly owned subsidiary.
Advisory vote on compensation for named executive officers in connection with the merger.
Approval to adjourn the meeting if additional proxy solicitation was needed.
Overview of voting outcomes
Merger Agreement Proposal was approved by a majority of outstanding shares.
Advisory Compensation Proposal was approved by a majority of outstanding shares.
Adjournment Proposal was not addressed as the merger was approved.
Final vote counts to be reported in a Form 8-K filing within four business days.
- Revenue up 186% in FY24; global expansion and pipeline drive 2025 growth targets.ESPR
Q4 20249 Jul 2026 - Next-gen ACLY inhibitor targets PSC with strong preclinical data and phase I trials planned for 2026.ESPR
Status Update8 Jul 2026 - Adjusted revenue up 63% year-over-year; U.S. net product revenue rose 41%; net loss $40.5M.ESPR
Q1 20258 Jul 2026 - Q2 revenue up 186% YoY, liquidity strengthened, and expanded labels fuel future growth.ESPR
Q2 20248 Jul 2026 - Stockholders will vote July 8, 2026, on a merger with Essence Parent Inc. after regulatory clearance.ESPR
Proxy filing16 Jun 2026 - Shareholders to vote on merger with $3.16 cash per share plus CVR; Board recommends approval.ESPR
Proxy filing8 Jun 2026 - Shareholders to vote on a merger with $3.16/share cash and CVR; board recommends approval.ESPR
Proxy filing29 May 2026 - All proposals passed, with no shareholder questions and strong support for board recommendations.ESPR
AGM 202628 May 2026 - Corstasis acquisition and sustained growth drive expansion in heart failure and global markets.ESPR
The Citizens Life Sciences Conference 202617 May 2026
Next Esperion Therapeutics earnings date
Next Esperion Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)